Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-06-07
2000-02-01
Guzo, David
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4353201, 514 44, C12N 1563, A61K 3170
Patent
active
060199806
ABSTRACT:
Vectors containing a nucleotide sequence coding for an F protein of respiratory syncytial virus (RSV) and a promoter for such sequence, preferably a cytomegalovirus promoter, are described. Such vectors also may contain a further nucleotide sequence located adjacent to the RSV F protein encoding sequence to enhance the immunoprotective ability of the RSV F protein when expressed in vivo. Such vectors may be used to immunize a host, including a human host, by administration thereto. Such vectors also may be used to produce antibodies for detection of RSV infection in a sample.
REFERENCES:
patent: 5149650 (1992-09-01), Wertz et al.
Chanock, Robert M. et al, Pediatrics vol. 90 No. 1, Jul. 1992, pp. 137-142.
Prince et al, J. Virol., 61:1851-1854, Jun. 1987.
Crowe et al, PNAS 91:1386-1390, Feb. 1994.
Prince et al, J. Virol. 55:517; Virus Res. 3; 193-206, 1985.
Groothuis et al, N. Engl. J. Med. 329:1524-1530, Nov. 1993.
Walsh et al, J. Infec. Dis., 155: 1198-1204, Jun. 1987.
Paradiso et al, Pediatr. Infect. Dis. J. 13:792-798, 1994.
Hemming et al, J. Infect. Dis., 152:1083-1087, (1985).
Tang et al. (1993) J. Biol. Chem. 268:9522-9525.
Collis et al. (1990) EMBO J. 9:233-240.
Ewashysyn Mary E.
Klein Michel H.
Li Xiaomao
Connaught Laboratories Limited
Guzo David
Schwartzman Robert
LandOfFree
Nucleic acid respiratory syncytial virus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid respiratory syncytial virus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid respiratory syncytial virus vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-935220